Status:

UNKNOWN

Efficacy of rTMS and tDCS as Adjunctive Rehabilitation for Cerebrovascular Disease-related Gait Dysfunction

Lead Sponsor:

zsneurology

Conditions:

Repetitive Transcranial Magnetic Stimulation

Transcranial Direct Current Stimulation

Eligibility:

All Genders

35-75 years

Phase:

NA

Brief Summary

This study was a prospective, randomized, single-blind, parallel-controlled, multicenter clinical study to evaluate the efficacy and safety of repetitive transcranial magnetic stimulation and transcra...

Detailed Description

This study was a prospective, randomized, single-blind, parallel-controlled, multicenter clinical study. The main purpose was to evaluate the efficacy and safety of repetitive transcranial magnetic st...

Eligibility Criteria

Inclusion

  • Group A: Gait Dysfunction of Hemiplegia
  • Age ≥ 35 years old, ≤ 75 years old;
  • There was a cerebral infarction event in the past ≥ 2 months, leaving unilateral lower extremity paralysis, muscle strength IV to V- grade;
  • Brunnstrom staging: lower limb of paralysis (IV-V grade), lower limb of healthy side (IV-V grade), upper limbs (IV-V grade), hands (IV-V grade);
  • Able to stand for 5 minutes without assistance, without gait aid, and to walk independently for 5 minutes without stopping;
  • Mini-mental state examination (MMSE) \> 17 points, able to complete cognitive and gait assessments.
  • Group B: Frontal Gait Dysfunction
  • Age ≥ 35 years old, ≤ 75 years old;
  • Meet the frontal gait characteristics: a) Balance dysfunction: wide step base, trunk swing, increased fall, decreased trunk movement control, and autonomous activity dysfunction; b) difficulty in starting, dragging and freezing; c) without limb ataxia, dysarthria, nystagmus, decreased facial expression, decreased upper limb joint activity, upper motor neuron impaired signs, and resting tremor;
  • There was a cerebral infarction event ≥ 2 months, or asymptomatic stroke event but the head MRI suggested single or multiple lacunar infarction or ischemic lesion (diameter ≤ 2cm);
  • limb muscle strength V- to V grade, and the muscle strength of both limbs is the same;
  • Able to stand for 5 minutes without assistance, without gait aid, to walk independently for 5 minutes;
  • Able to complete cognitive and gait assessments.

Exclusion

  • Other gait abnormalities caused by other diseases, such as Parkinson's disease, hydrocephalus, cerebellar disease, vestibular system disease, extrapyramidal abnormalities, abnormalities of proprioceptive sensibility, visual abnormalities, auditory abnormalities, peripheral nerves and musculoskeletal diseases;
  • Symptomatic cerebral infarction \<2 months; Severe nervous system diseases, such as previous cerebral hemorrhage, history of subarachnoid hemorrhage, craniocerebral trauma, cerebral vascular malformation, brain tumor, central nervous system infection, demyelinating disease, epilepsy, myelopathy, etc.;
  • Severe cognitive impairment, major depression, and aphasia disable to finish the cognitive and gait assessments;
  • serious cardiovascular, pulmonary, blood, rheumatism and other complications, pregnancy;
  • Metal implants such as pacemakers or cochlear implants;
  • Taking drugs that affect cortical excitability: such as antiepileptic drugs, sedation, benzodiazepines, antidepressants, dopamine, amphetamines, etc.;
  • long-term heavy drinking: the alcohol content of men drinking more than 168g per week, women more than 112g;
  • Neurological rehabilitation treatment was received within 1 month before the start of the trial.

Key Trial Info

Start Date :

December 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2020

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04282538

Start Date

December 1 2018

End Date

December 31 2020

Last Update

February 24 2020

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Shanghai Zhongshan Hospital

Shanghai, Shanghai Municipality, China, 200032

2

Shanghai Eighth People's Hospital

Shanghai, Shanghai Municipality, China

3

Shanghai Huadong Hospital

Shanghai, Shanghai Municipality, China

4

Shanghai Sixth People's Hospital

Shanghai, Shanghai Municipality, China

Efficacy of rTMS and tDCS as Adjunctive Rehabilitation for Cerebrovascular Disease-related Gait Dysfunction | DecenTrialz